. Author manuscript; available in PMC: 2017 Sep 1.

Published in final edited form as: Int J Cardiol. 2016 May 13;218:206–211. doi: 10.1016/j.ijcard.2016.05.015

Table 6.

Cardiac MRI variables of right ventricular function at diagnosis and following 3–8 months of therapy in 42 PAH patients.

CMR Variable	Baseline	3–8 months therapy	p value
RVEF (%)	35 ± 16	39 ± 15	0.002
SV/ESV	0.43 (0.29 – 0.85)	0.62 (0.36 – 1.099)	0.008
RVESVI (mL/m²)	61 ± 30	56 ± 26	0.036
RVEDVI (mL/m²)	93 (66 – 109)	92 (53 – 118)	0.726
SVI (mL/m²)	27 ± 8	32 ± 9	0.004

Data shown mean ± sd or median (IQR) depending on data distribution.

CMR: cardiac MRI; RVEF: right ventricular ejection fraction; SV/ESV: RV coupling volumetric method; RVESVI: right ventricular end systolic volume index; RVEDVI: right ventricular end diastolic volume index; SVI: stroke volume index.